Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:LLY
NYSE:LLYPharmaceuticals

Eli Lilly (LLY) Net Margin Surge Tests Justification For Premium 48x P/E

Eli Lilly (LLY) just closed out FY 2025 with fourth quarter revenue of US$19.3b and basic EPS of US$7.39, capping a year where trailing twelve month revenue reached US$65.2b and EPS came in at US$22.95. Over the last six reported quarters, revenue has moved from US$13.5b in Q4 2024 to US$19.3b in Q4 2025, while quarterly EPS shifted from US$4.88 to US$7.39 as the business scaled. With trailing net profit margins sitting well above last year and earnings growth outpacing revenue, the latest...
NYSE:JCI
NYSE:JCIBuilding

Johnson Controls International (JCI) Margin Expansion And EPS Growth Test Bullish Narratives In Q1 2026

Johnson Controls International (JCI) opened Q1 2026 with revenue of US$5.8b and basic EPS of US$0.91, setting a clear benchmark for how its earnings story is developing this year. The company has seen quarterly revenue move from US$5.4b in Q1 2025 to US$5.8b in Q1 2026, while basic EPS shifted from US$0.55 to US$0.91 over the same periods, pointing to a tighter link between sales and profitability. With trailing 12 month earnings growth and margin expansion already on the radar, this latest...
NasdaqCM:SLNO
NasdaqCM:SLNOBiotechs

What Soleno Therapeutics (SLNO)'s VYKAT XR Momentum and 2025 Outlook Could Mean For Shareholders

Soleno Therapeutics recently highlighted what it called a transformational 2025 for VYKAT XR, pointing to strong preliminary revenue and plans to release full financial results in late February. The company is also preparing for a series of investor conferences beginning 12 February, which could further spotlight its rare disease portfolio, including Diazoxide Choline Extended-Release tablets in Phase III trials for Prader-Willi Syndrome. We’ll now examine how enthusiasm around VYKAT XR’s...
ENXTPA:PUB
ENXTPA:PUBMedia

Publicis Groupe Ties Cancer Support And AI Push To Long Term Story

Publicis Groupe (ENXTPA:PUB) has expanded its global "Working with Cancer" program, adding new tools and policies to support employees affected by cancer. The company introduced an AI powered coaching tool and drew on research from leading cancer centers to shape its approach. In the Middle East, Publicis Groupe launched "The Majlis of Possible," a platform aimed at bringing together government and private sector leaders. These moves come alongside ongoing work by Publicis Groupe to apply...
AIM:VLX
AIM:VLXElectrical

European Undervalued Small Caps With Insider Action To Consider

As the European market navigates a modest recovery, highlighted by a 1.5% GDP growth in 2025 and improved consumer confidence, small-cap stocks remain an intriguing segment for investors seeking potential opportunities amidst mixed performances across major indices. In this environment of cautious optimism, identifying small-cap companies with strong fundamentals and insider activity can be key to uncovering promising investment prospects.
SWX:HUBN
SWX:HUBNElectrical

European Value Stocks Trading Below Estimated Worth In February 2026

As the European markets navigate a landscape marked by earnings optimism amidst trade and geopolitical concerns, the pan-European STOXX Europe 600 Index has shown resilience with modest gains. Against this backdrop, identifying stocks that are trading below their estimated worth can offer potential opportunities for investors seeking value in an environment where confidence is strengthening and economic recovery continues at a steady pace.
DB:0QM
DB:0QMHospitality

European Penny Stocks To Watch In February 2026

As the European market shows signs of modest recovery, with the pan-European STOXX Europe 600 Index gaining 0.44% amidst mixed performances across major indices, investors are cautiously optimistic about future growth prospects. In such a climate, penny stocks—though an outdated term—remain relevant as they often represent smaller or newer companies that can offer unique investment opportunities. These stocks, when backed by strong fundamentals and financial resilience, present potential for...
OM:LOOMIS
OM:LOOMISCommercial Services

Top European Dividend Stocks To Watch In February 2026

As the eurozone economy continues its modest recovery with strengthened confidence and investment, European markets have shown resilience despite mixed performances among major stock indexes. In this environment, dividend stocks can offer investors a potential source of steady income and stability, making them an attractive option to consider as part of a diversified portfolio.
NYSE:BMI
NYSE:BMIElectronic

Badger Meter Leans Into Smart Water Software With PRASA Win And Integration

Badger Meter, NYSE:BMI, secured the PRASA AMI project in Puerto Rico, expanding its smart water footprint into a key international market. The company completed the integration of SmartCover into its BlueEdge smart water management platform, broadening its digital monitoring capabilities. These moves reflect progress in smart water infrastructure projects beyond regular earnings updates. Badger Meter enters this news cycle with its shares at $146.31 and a mixed recent track record,...
NYSE:CMC
NYSE:CMCMetals and Mining

Is CMC’s ESG Accolades And Insider Buying Recasting Commercial Metals’ (CMC) Investment Narrative?

In early 2026, Commercial Metals Company was named to Corporate Knights’ Global 100 Most Sustainable Corporations and the Clean200, while director Dennis V. Arriola increased his direct shareholdings through an open-market purchase. These sustainability accolades, combined with insider buying, highlight a growing environmental profile that may broaden the company’s appeal among ESG-oriented investors. We’ll now examine how this combination of sustainability recognition and insider share...